AURORA, ON–(Marketwire – March 22, 2011) – Helix BioPharma Corp. (TSX: HBP) (NYSE Amex: HBP) (FRANKFURT: HBP), a developer of biopharmaceutical drug candidates for the prevention and treatment of cancer, today announced that Baomin Tian, Ph.D., senior …
Some local news is curated – Original might have been posted at a different date/ time! Click the source link for details.
